PH-responsive nanoparticles releasing tenofovir intended for the prevention of HIV transmission

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 79, Issue 3, 2011, Pages 526-536

  Zhang, Tao ^a   Sturgis, Timothy F ^a   Youan, Bi Botti C ^a  

^a UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

Author keywords

HIV AIDS microbicide; Nanoparticles; pH responsive; Tenofovir; Tenofovir disoproxil fumarate; Topical delivery

Indexed keywords

EUDRAGIT; NANOPARTICLE; POLYGLACTIN; TENOFOVIR; TENOFOVIR DISOPROXIL;

ARTICLE; CELL VIABILITY; CONFOCAL MICROSCOPY; CYTOTOXICITY; DRUG RELEASE; FEMALE; FLUORESCENCE SPECTROSCOPY; HUMAN; HUMAN CELL; LACTOBACILLUS; LACTOBACILLUS CRISPATUS; NONHUMAN; PARTICLE SIZE; PH; PHYSICOCHEMICAL MODEL; SPECTROPHOTOMETRY; TRANSMISSION ELECTRON MICROSCOPY; VAGINA EPITHELIUM; ZETA POTENTIAL;

ADENINE; ADMINISTRATION, INTRAVAGINAL; ANTI-HIV AGENTS; CELL LINE; CELL SURVIVAL; DRUG CARRIERS; DRUG COMPOUNDING; EPITHELIAL CELLS; FEMALE; HIV INFECTIONS; HUMANS; HYDROGEN-ION CONCENTRATION; LACTIC ACID; LACTOBACILLUS; MICROSCOPY, CONFOCAL; MICROSCOPY, ELECTRON, TRANSMISSION; MICROSCOPY, FLUORESCENCE; NANOPARTICLES; PARTICLE SIZE; PHOSPHONIC ACIDS; POLYGLYCOLIC ACID; POLYMETHACRYLIC ACIDS; SOLUBILITY; SURFACE PROPERTIES; VAGINA;

EID: 80053960975     PISSN: 09396411     EISSN: 18733441     Source Type: Journal    
DOI: 10.1016/j.ejpb.2011.06.007     Document Type: Article

References (59)

1. UNAIDS/WHO, Report on Global AIDS Epidemic, in: UNAIDS, Geneva, 2009, p. 362.
2. B. Auvert, D. Taljaard, E. Lagarde, J. Sobngwi-Tambekou, R. Sitta, and A. Puren Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 trial PLoS Med. 2 2005 e298
3. R. Pool, G. Hart, G. Green, S. Harrison, S. Nyanzi, and J. Whitworth Men's attitudes to condoms and female controlled means of protection against HIV and STDs in south-western Uganda Cult. Health Sex. 2 2000 197 211
4. N. Chattopadhyay, J. Zastre, H.L. Wong, X.Y. Wu, and R. Bendayan Solid lipid nanoparticles enhance the delivery of the HIV protease inhibitor, atazanavir, by a human brain endothelial cell line Pharm. Res. 25 2008 2262 2271
5. R. Asasutjarit, S.I. Lorenzen, S. Sirivichayakul, K. Ruxrungtham, U. Ruktanonchai, and G.C. Ritthidej Effect of solid lipid nanoparticles formulation compositions on their size, zeta potential and potential for in vitro pHIS-HIV-hugag transfection Pharm. Res. 24 2007 1098 1107 (Pubitemid 46798889)
6. L. Baert, G. van 't Klooster, W. Dries, M. Francois, A. Wouters, E. Basstanie, K. Iterbeke, F. Stappers, P. Stevens, L. Schueller, P. Van Remoortere, G. Kraus, P. Wigerinck, and J. Rosier Development of a long-acting injectable formulation with nanoparticles of rilpivirine (TMC278) for HIV treatment Eur. J. Pharm. Biopharm. 72 2009 502 508
7. C.K. Mauck, D.H. Weiner, M.D. Creinin, K.T. Barnhart, M.M. Callahan, and R. Bax A randomized phase I vaginal safety study of three concentrations of C31G vs. extra strength Gynol II Contraception 70 2004 233 240 (Pubitemid 39119986)
8. R.S. Veazey, P.J. Klasse, S.M. Schader, Q. Hu, T.J. Ketas, M. Lu, P.A. Marx, J. Dufour, R.J. Colonno, R.J. Shattock, M.S. Springer, and J.P. Moore Protection of macaques from vaginal SHIV challenge by vaginally delivered inhibitors of virus-cell fusion Nature 438 2005 99 102 (Pubitemid 41599827)
9. V. Dubey, D. Mishra, M. Nahar, V. Jain, and N.K. Jain Enhanced transdermal delivery of an anti-HIV agent via ethanolic liposomes Nanomedicine 6 2010 590 596
10. C. Goddeeris, T. Willems, K. Houthoofd, J.A. Martens, and G. Van den Mooter Dissolution enhancement of the anti-HIV drug UC 781 by formulation in a ternary solid dispersion with TPGS 1000 and Eudragit E100 Eur. J. Pharm. Biopharm. 70 2008 861 868
11. Q.A. Karim, S.S. Karim, J.A. Frohlich, A.C. Grobler, C. Baxter, L.E. Mansoor, A.B. Kharsany, S. Sibeko, K.P. Mlisana, Z. Omar, T.N. Gengiah, S. Maarschalk, N. Arulappan, M. Mlotshwa, L. Morris, and D. Taylor Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women Science 329 2010 1168 1174
12. T.J. Johnson, K.M. Gupta, J. Fabian, T.H. Albright, and P.F. Kiser Segmented polyurethane intravaginal rings for the sustained combined delivery of antiretroviral agents dapivirine and tenofovir Eur. J. Pharm. Sci. 39 2010 203 212
13. U.M. Parikh, C. Dobard, S. Sharma, M.E. Cong, H. Jia, A. Martin, C.P. Pau, D.L. Hanson, P. Guenthner, J. Smith, E. Kersh, J.G. Garcia-Lerma, F.J. Novembre, R. Otten, T. Folks, and W. Heneine Complete protection from repeated vaginal simian-human immunodeficiency virus exposures in macaques by a topical gel containing tenofovir alone or with emtricitabine J. Virol. 83 2009 10358 10365
14. A. Carballo-Dieguez, I.C. Balan, K. Morrow, R. Rosen, J.E. Mantell, F. Gai, S. Hoffman, L. Maslankowski, W. El-Sadr, and K. Mayer Acceptability of tenofovir gel as a vaginal microbicide by US male participants in a phase I clinical trial (HPTN 050) AIDS Care 19 2007 1026 1031 (Pubitemid 47402895)
15. A.D. Woolfson, M.L. Umrethia, V.L. Kett, and R.K. Malcolm Freeze-dried, mucoadhesive system for vaginal delivery of the HIV microbicide, dapivirine: optimisation by an artificial neural network Int. J. Pharm. 388 2010 136 143
16. R.J. Morrow, A.D. Woolfson, L. Donnelly, R. Curran, G. Andrews, D. Katinger, and R.K. Malcolm Sustained release of proteins from a modified vaginal ring device Eur. J. Pharm. Biopharm. 77 2011 3 10
17. S. Garg, K. Vermani, A. Garg, R.A. Anderson, W.B. Rencher, and L.J. Zaneveld Development and characterization of bioadhesive vaginal films of sodium polystyrene sulfonate (PSS), a novel contraceptive antimicrobial agent Pharm. Res. 22 2005 584 595 (Pubitemid 40603256)
18. L.C. du Toit, V. Pillay, and Y.E. Choonara Nano-microbicides: challenges in drug delivery, patient ethics and intellectual property in the war against HIV/AIDS Adv. Drug Deliv. Rev. 62 2010 532 546
19. T. Mamo, E.A. Moseman, N. Kolishetti, C. Salvador-Morales, J. Shi, D.R. Kuritzkes, R. Langer, U. von Andrian, and O.C. Farokhzad Emerging nanotechnology approaches for HIV/AIDS treatment and prevention Nanomedicine (Lond.) 5 2010 269 285
20. A.S. Ham, M.R. Cost, A.B. Sassi, C.S. Dezzutti, and L.C. Rohan Targeted delivery of PSC-RANTES for HIV-1 prevention using biodegradable nanoparticles Pharm. Res. 26 2009 502 511
21. K.A. Woodrow, Y. Cu, C.J. Booth, J.K. Saucier-Sawyer, M.J. Wood, and W.M. Saltzman Intravaginal gene silencing using biodegradable polymer nanoparticles densely loaded with small-interfering RNA Nat. Mater. 8 2009 526 533
22. D.H. Owen, and D.F. Katz A review of the physical and chemical properties of human semen and the formulation of a semen simulant J. Androl. 26 2005 459 469 (Pubitemid 40847857)
23. K.M. Gupta, S.R. Barnes, R.A. Tangaro, M.C. Roberts, D.H. Owen, D.F. Katz, and P.F. Kiser Temperature and pH sensitive hydrogels: an approach towards smart semen-triggered vaginal microbicidal vehicles J. Pharm. Sci. 96 2007 670 681 (Pubitemid 46466087)
24. Y. Jiao, N. Ubrich, M. Marchand-Arvier, C. Vigneron, M. Hoffman, T. Lecompte, and P. Maincent In vitro and in vivo evaluation of oral heparin-loaded polymeric nanoparticles in rabbits Circulation 105 2002 230 235 (Pubitemid 34084324)
25. K. Dillen, C. Bridts, P. Van der Veken, P. Cos, J. Vandervoort, K. Augustyns, W. Stevens, and A. Ludwig Adhesion of PLGA or Eudragit/PLGA nanoparticles to Staphylococcus and Pseudomonas Int. J. Pharm. 349 2008 234 240
26. K. Dillen, J. Vandervoort, G. Van den Mooter, and A. Ludwig Evaluation of ciprofloxacin-loaded Eudragit RS100 or RL100/PLGA nanoparticles Int. J. Pharm. 314 2006 72 82
27. A. Basarkar, and J. Singh Poly (lactide-co-glycolide)-polymethacrylate nanoparticles for intramuscular delivery of plasmid encoding interleukin-10 to prevent autoimmune diabetes in mice Pharm. Res. 26 2009 72 81
28. E. Glowka, A. Sapin-Minet, P. Leroy, J. Lulek, and P. Maincent Preparation and in vitro-in vivo evaluation of salmon calcitonin-loaded polymeric nanoparticles J. Microencapsul. 27 2010 25 36
29. M. Cetin, A. Atila, and Y. Kadioglu Formulation and in vitro characterization of Eudragit(R) L100 and Eudragit(R) L100-PLGA nanoparticles containing diclofenac sodium AAPS PharmSciTech 11 2010 1250 1256
30. D. Jain, A.K. Panda, and D.K. Majumdar Eudragit S100 entrapped insulin microspheres for oral delivery AAPS PharmSciTech 6 2005 E100 E107 (Pubitemid 41644139)
31. H. Murakami, M. Kobayashi, H. Takeuchi, and Y. Kawashima Preparation of poly(dl-lactide-co-glycolide) nanoparticles by modified spontaneous emulsification solvent diffusion method Int. J. Pharm. 187 1999 143 152 (Pubitemid 29443894)
32. D.H. Owen, and D.F. Katz A vaginal fluid simulant Contraception 59 1999 91 95 (Pubitemid 29244754)
33. T. Tsukatani, H. Suenaga, T. Higuchi, T. Akao, M. Ishiyama, K. Ezoe, and K. Matsumoto Colorimetric cell proliferation assay for microorganisms in microtiter plate using water-soluble tetrazolium salts J. Microbiol. Methods 75 2008 109 116
34. J.H. Jorgenson, J.D. Turnidge, and J.A. Washington Antibacterial susceptibility tests: dilution and disk diffusion methods P.R. Murray, E.J. Baron, M.A. Pfaller, F.C. Tenover, R.H. Yolken, Manual of Clinical Microbiology 1999 ASM Press Washington, DC
35. J. Xie, and C.H. Wang Self-assembled biodegradable nanoparticles developed by direct dialysis for the delivery of paclitaxel Pharm. Res. 22 2005 2079 2090 (Pubitemid 41821587)
36. K.L. Douglas, C.A. Piccirillo, and M. Tabrizian Cell line-dependent internalization pathways and intracellular trafficking determine transfection efficiency of nanoparticle vectors Eur. J. Pharm. Biopharm. 68 2008 676 687 (Pubitemid 351318216)
37. H.K. Ibrahim, I.S. El-Leithy, and A.A. Makky Mucoadhesive nanoparticles as carrier systems for prolonged ocular delivery of gatifloxacin/prednisolone bitherapy Mol. Pharm. 7 2010 576 585
38. M.P. Desai, V. Labhasetwar, G.L. Amidon, and R.J. Levy Gastrointestinal uptake of biodegradable microparticles: effect of particle size Pharm. Res. 13 1996 1838 1845 (Pubitemid 27034116)
39. S.U. Choi, T. Bui, and R.J. Ho pH-dependent interactions of indinavir and lipids in nanoparticles and their ability to entrap a solute J. Pharm. Sci. 97 2008 931 943 (Pubitemid 351293892)
40. FDA Viread prescribing information, in: U.F.a.D. Administration (Ed.), 2008.
41. D. Klose, F. Siepmann, K. Elkharraz, and J. Siepmann PLGA-based drug delivery systems: importance of the type of drug and device geometry Int. J. Pharm. 354 2008 95 103 (Pubitemid 351410450)
42. S.I. Badawy, and M.A. Hussain Microenvironmental pH modulation in solid dosage forms J. Pharm. Sci. 96 2007 948 959 (Pubitemid 46797467)
43. L. Li, and S.P. Schwendeman Mapping neutral microclimate pH in PLGA microspheres J. Control. Release 101 2005 163 173 (Pubitemid 39600980)
44. D.A. Nguyen, and H.S. Fogler Facilitated diffusion in the dissolution of carboxylic polymers AIChE J. 51 2005 415 425 (Pubitemid 40321674)
45. C. Tevi-Benissan, L. Belec, M. Levy, V. Schneider-Fauveau, A. Si Mohamed, M.C. Hallouin, M. Matta, and G. Gresenguet In vivo semen-associated pH neutralization of cervicovaginal secretions Clin. Diagn. Lab. Immunol. 4 1997 367 374 (Pubitemid 27239700)
46. B.S. Zolnik, and D.J. Burgess Effect of acidic pH on PLGA microsphere degradation and release J. Control. Release 122 2007 338 344 (Pubitemid 47404676)
47. M.L. Houchin, S.A. Neuenswander, and E.M. Topp Effect of excipients on PLGA film degradation and the stability of an incorporated peptide J. Control. Release 117 2007 413 420 (Pubitemid 46216583)
48. L. Mu, and S.S. Feng A novel controlled release formulation for the anticancer drug paclitaxel (Taxol): PLGA nanoparticles containing vitamin E TPGS J. Control. Release 86 2003 33 48 (Pubitemid 35469120)
49. W.A. Lee, G.X. He, E. Eisenberg, T. Cihlar, S. Swaminathan, A. Mulato, and K.C. Cundy Selective intracellular activation of a novel prodrug of the human immunodeficiency virus reverse transcriptase inhibitor tenofovir leads to preferential distribution and accumulation in lymphatic tissue Antimicrob. Agents Chemother. 49 2005 1898 1906 (Pubitemid 40631605)
50. A.B. Sassi, C.E. Isaacs, B.J. Moncla, P. Gupta, S.L. Hillier, and L.C. Rohan Effects of physiological fluids on physical-chemical characteristics and activity of topical vaginal microbicide products J. Pharm. Sci. 97 2008 3123 3139
51. A. Mahalingam, E. Smith, J. Fabian, F.R. Damian, J.J. Peters, M.R. Clark, D.R. Friend, D.F. Katz, and P.F. Kiser Design of a semisolid vaginal microbicide gel by relating composition to properties and performance Pharm. Res. 27 2010 2478 2491
52. M.M. Lederman, R.E. Offord, and O. Hartley Microbicides and other topical strategies to prevent vaginal transmission of HIV Nat. Rev. Immunol. 6 2006 371 382
53. L.C. Rohan, B.J. Moncla, R.P. Kunjara Na Ayudhya, M. Cost, Y. Huang, F. Gai, N. Billitto, J.D. Lynam, K. Pryke, P. Graebing, N. Hopkins, J.F. Rooney, D. Friend, and C.S. Dezzutti In vitro and ex vivo testing of tenofovir shows it is effective as an HIV-1 microbicide PLoS One 5 2010 e9310
54. R.N. Fichorova, M. Bajpai, N. Chandra, J.G. Hsiu, M. Spangler, V. Ratnam, and G.F. Doncel Interleukin (IL)-1, IL-6, and IL-8 predict mucosal toxicity of vaginal microbicidal contraceptives Bio. Reprod. 71 2004 761 769 (Pubitemid 39108635)
55. R.N. Fichorova, and D.J. Anderson Differential expression of immunobiological mediators by immortalized human cervical and vaginal epithelial cells Biol. Reprod. 60 1999 508 514 (Pubitemid 29063896)
56. S. Garg, K.R. Tambweker, K. Vermani, A. Garg, C.L. Kaul, and L.J. Zaneveld Compendium of pharmaceutical excipients for vaginal formulations Pharm. Technol. Drug Deliv. 11 2001 14 24 (Pubitemid 33051614)
57. S.J. Klebanoff, and R.W. Coombs Viricidal effect of Lactobacillus acidophilus on human immunodeficiency virus type 1: possible role in heterosexual transmission J. Exp. Med. 174 1991 289 292
58. M. Wilks, R. Wiggins, A. Whiley, E. Hennessy, S. Warwick, H. Porter, A. Corfield, and M. Millar Identification and H(2)O(2) production of vaginal lactobacilli from pregnant women at high risk of preterm birth and relation with outcome J. Clin. Microbiol. 42 2004 713 717 (Pubitemid 38222651)
59. J. Rejman, V. Oberle, I.S. Zuhorn, and D. Hoekstra Size-dependent internalization of particles via the pathways of clathrin- and caveolae-mediated endocytosis Biochem. J. 377 2004 159 169 (Pubitemid 38114443)